======= POLR1C =======
== Gene Information ==
* **Official Symbol**: POLR1C
* **Official Name**: RNA polymerase I and III subunit C
* **Aliases and Previous Symbols**: N/A
* **Entrez ID**: [[https://www.ncbi.nlm.nih.gov/gene/?term=9533|9533]]
* **UniProt**: [[https://www.uniprot.org/uniprot/O15160|O15160]]
* **Interactions**: [[https://thebiogrid.org/search.php?search=POLR1C&organism=9606|BioGRID]]
* **PubMed articles**: [[https://www.ncbi.nlm.nih.gov/pubmed/?term=gene%20POLR1C|Open PubMed]]
* **OMIM**: [[https://omim.org/entry/610060|Open OMIM]]
== Function Summary ==
* **Entrez Summary**: The protein encoded by this gene is a subunit of both RNA polymerase I and RNA polymerase III complexes. The encoded protein is part of the Pol core element. Mutations in this gene have been associated with Treacher Collins syndrome (TCS) and hypomyelinating leukodystrophy 11. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Jan 2016].
* **UniProt Summary**: DNA-dependent RNA polymerase catalyzes the transcription of DNA into RNA using the four ribonucleoside triphosphates as substrates. Common component of RNA polymerases I and III which synthesize ribosomal RNA precursors and small RNAs, such as 5S rRNA and tRNAs, respectively. RPAC1 is part of the Pol core element with the central large cleft and probably a clamp element that moves to open and close the cleft (By similarity). {ECO:0000250|UniProtKB:P07703, ECO:0000305|PubMed:26151409}.
|RNA pol A bac|
|RNA pol L|
|RNA polymerase I complex|
|RNA polymerase I activity|
|RNA polymerase III activity|
|RNA polymerase III complex|
|transcription elongation from RNA polymerase I promoter|
|termination of RNA polymerase I transcription|
|DNA-directed 5-3 RNA polymerase activity|
|transcription initiation from RNA polymerase I promoter|
|transcription by RNA polymerase I|
|transcription by RNA polymerase III|
|positive regulation of gene expression, epigenetic|
|DNA-templated transcription, termination|
|positive regulation of type I interferon production|
|DNA-templated transcription, elongation|
|regulation of type I interferon production|
|protein dimerization activity|
|DNA-templated transcription, initiation|
|regulation of gene expression, epigenetic|
|positive regulation of cytokine production|
|transcription, DNA-templated|
|nucleic acid-templated transcription|
|RNA biosynthetic process|
|regulation of cytokine production|
|nucleobase-containing compound biosynthetic process|
|heterocycle biosynthetic process|
|aromatic compound biosynthetic process|
|organic cyclic compound biosynthetic process|
|DNA binding|
|cellular nitrogen compound biosynthetic process|
|RNA metabolic process|
|cellular macromolecule biosynthetic process|
|positive regulation of multicellular organismal process|
|macromolecule biosynthetic process|
|positive regulation of gene expression|
|gene expression|
\\
=== CRISPR Data ===
^Screen^Score^
|[[:results:exp291|LLY-284 2.6μM R06 exp291]]|-1.81|
|[[:results:exp526|Sulforaphane 9μM R08 exp526 no dilution day6]]|1.93|
^Gene^Correlation^
|[[:human genes:p:polr2j3|POLR2J3]]|0.46|
Global Fraction of Cell Lines Where Essential: 726/726
^Tissue^Fraction Of Cell Lines Where Essential^
|1290807.0|1/1|
|909776.0|1/1|
|bile duct|28/28|
|blood|28/28|
|bone|25/25|
|breast|33/33|
|central nervous system|56/56|
|cervix|4/4|
|colorectal|17/17|
|esophagus|13/13|
|fibroblast|1/1|
|gastric|15/15|
|kidney|21/21|
|liver|20/20|
|lung|75/75|
|lymphocyte|14/14|
|ovary|26/26|
|pancreas|24/24|
|peripheral nervous system|16/16|
|plasma cell|15/15|
|prostate|1/1|
|skin|24/24|
|soft tissue|7/7|
|thyroid|2/2|
|upper aerodigestive|22/22|
|urinary tract|29/29|
|uterus|5/5|
== Essentiality in NALM6 ==
* **Essentiality Rank**: 707
* **Expression level (log2 read counts)**: 5.56
{{:chemogenomics:nalm6 dist.png?nolink |}}